• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Factors affecting the pharmacokinetics of diclofenac sodium (Voltarol).

作者信息

Kendall M J, Thornhill D P, Willis J V

出版信息

Rheumatol Rehabil. 1979;Suppl 2:38-46.

PMID:531447
Abstract

The blood level curves of diclofenac have been studied following its administration to young and old volunteers, and results of studies performed on olderly patients and those with renal disease are reported. The investigations on young volunteers show that when the enteric-coated tablets are taken there is a delay in the onset of absorption but thereafter absorption and elimination are rapid, with a terminal elimination half-life of 1.2 hours. The relevance of these observations to the patient who is receiving the drug chronically and who is older, ill and often on drugs is discussed. Clearly, all the different factors which may affect the handling of the drug have not yet been evaluated, but the studies carried out so far suggest that the blood level profile obtained is not materially affected by age, renal impairment or chronic administration.

摘要

相似文献

1
Factors affecting the pharmacokinetics of diclofenac sodium (Voltarol).
Rheumatol Rehabil. 1979;Suppl 2:38-46.
2
The pharmacokinetics and metabolism of diclofenac sodium (Voltarol) in animals and man.双氯芬酸钠(扶他林)在动物和人体中的药代动力学及代谢情况。
Rheumatol Rehabil. 1979;Suppl 2:22-37.
3
Comparative bioavailability of two enteric-coated tablet preparations of diclofenac sodium.双氯芬酸钠两种肠溶衣片制剂的相对生物利用度
Int J Clin Pharmacol Res. 1987;7(4):239-42.
4
Clinical relevance of nonsteroidal anti-inflammatory drug pharmacokinetics.非甾体抗炎药药代动力学的临床相关性。
Eur J Rheumatol Inflamm. 1987;8(1):18-23.
5
[Pharmacokinetics and biological availability of diclofenac preparations following intramuscular injection of 75 mg and oral administration of 150 mg of active drug].
Z Rheumatol. 1988 Jan-Feb;47(1):37-42.
6
Comparative bioavailability of a dispersible formulation of diclofenac and finding of double plasma peaks.双氯芬酸分散片剂的相对生物利用度及双血浆峰的发现
Int J Clin Pharmacol Ther. 1995 Jun;33(6):333-9.
7
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.双氯芬酸钠静脉注射和口服给药后的药代动力学。
Eur J Clin Pharmacol. 1979;16(6):405-10. doi: 10.1007/BF00568201.
8
Pharmacokinetic studies in healthy volunteers on a new gastroprotective pharmaceutic form of diclofenac.对双氯芬酸一种新型胃保护药物剂型在健康志愿者身上进行的药代动力学研究。
Arzneimittelforschung. 1993 Mar;43(3):373-7.
9
[Comparative bioavailability and pharmacokinetics of Dolotren retard and Dolotren].[多洛特伦缓释片与多洛特伦的生物利用度比较及药代动力学研究]
Rev Med Univ Navarra. 1992 Jan-Mar;37(1):7-16.
10
Pharmacokinetics of diclofenac sodium in normal man.双氯芬酸钠在正常人体内的药代动力学。
Pak J Pharm Sci. 2005 Jan;18(1):18-24.

引用本文的文献

1
Intestinal Metabolism of Diclofenac by Polymorphic UGT2B17 Correlates with its Highly Variable Pharmacokinetics and Safety across Populations.多态性 UGT2B17 对双氯芬酸的肠道代谢与其在人群中的高度可变药代动力学和安全性相关。
Clin Pharmacol Ther. 2023 Jul;114(1):161-172. doi: 10.1002/cpt.2907. Epub 2023 Apr 29.
2
Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology.非甾体抗炎药(NSAID)的发展进展:运用制药技术的双氯芬酸产品的演变
Drugs. 2015 May;75(8):859-77. doi: 10.1007/s40265-015-0392-z.
3
Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.
双氯芬酸的临床药代动力学。治疗见解与陷阱。
Clin Pharmacokinet. 1997 Sep;33(3):184-213. doi: 10.2165/00003088-199733030-00003.
4
Pharmacokinetics of diclofenac and misoprostol when administered alone or as a combination product.
Drugs. 1993;45 Suppl 1:7-13; discussion 14. doi: 10.2165/00003495-199300451-00004.
5
The pharmacokinetics of diclofenac sodium in patients with active rheumatoid disease.双氯芬酸钠在活动性类风湿疾病患者中的药代动力学。
Eur J Clin Pharmacol. 1982;21(4):331-4. doi: 10.1007/BF00637622.
6
Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin.双氯芬酸钠:其药理特性及在风湿性疾病和各种原因引起的疼痛中的治疗应用综述
Drugs. 1980 Jul;20(1):24-48. doi: 10.2165/00003495-198020010-00002.
7
The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly.非甾体抗炎药在老年人中的药代动力学。
Clin Pharmacokinet. 1987 Feb;12(2):111-22. doi: 10.2165/00003088-198712020-00002.
8
Lack of effect of a single-dose of sulglicotide on the bioavailability of diclofenac.单剂量舒糖核苷酸对双氯芬酸生物利用度无影响。
Eur J Clin Pharmacol. 1988;34(2):211-2. doi: 10.1007/BF00614561.
9
Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.双氯芬酸钠。对其药效学和药代动力学特性以及治疗效果的重新评估。
Drugs. 1988 Mar;35(3):244-85. doi: 10.2165/00003495-198835030-00004.
10
The pharmacokinetics of diclofenac sodium following intravenous and oral administration.双氯芬酸钠静脉注射和口服给药后的药代动力学。
Eur J Clin Pharmacol. 1979;16(6):405-10. doi: 10.1007/BF00568201.